Division of Anatomic Pathology and Histology-Fondazione, Policlinico Universitario "Agostino Gemelli"-IRCCS, Università Cattolica del Sacro Cuore, Largo Francesco Vito, 1, 00168, Rome, Italy.
Virchows Arch. 2024 Aug;485(2):197-212. doi: 10.1007/s00428-024-03856-y. Epub 2024 Jul 9.
Primary neuroendocrine neoplasms (NENs) of the breast are characterized by neuroendocrine architectural and cytological features, which must be supported by immunohistochemical positivity for neuroendocrine markers (such as Chromogranin and Synaptophysin). According to the literature, making a diagnosis of primary neuroendocrine breast cancer always needs to rule out a possible primary neuroendocrine neoplasm from another site. Currently, the latest 2022 version of the WHO of endocrine and neuroendocrine neoplasms has classified breast NENs as well-differentiated neuroendocrine tumours (NETs) and aggressive neuroendocrine carcinomas (NECs), differentiating them from invasive breast cancers of no special type (IBCs-NST). with neuroendocrine features. The current review article describes six cases from our series and a comprehensive review of the literature in the field of NENs of the breast.
乳腺原发性神经内分泌肿瘤(NEN)的特征是具有神经内分泌结构和细胞学特征,这必须通过神经内分泌标志物(如嗜铬粒蛋白和突触素)的免疫组织化学阳性来支持。根据文献,诊断原发性神经内分泌乳腺癌始终需要排除来自其他部位的可能的原发性神经内分泌肿瘤。目前,最新的 2022 版 WHO 内分泌和神经内分泌肿瘤将乳腺 NEN 分类为分化良好的神经内分泌肿瘤(NET)和侵袭性神经内分泌癌(NEC),将其与无特殊类型(IBC-NST)的浸润性乳腺癌区分开来。有神经内分泌特征。本文回顾了我们系列中的 6 例病例,并对乳腺 NEN 领域的文献进行了全面回顾。